Shabil Muhammed, Gaidhane Shilpa, Lakhanpal Sorabh, Irshaidat Sara, Ballal Suhas, Kumar Sanjay, Bhat Mahakshit, Sharma Shilpa, Ravi Kumar M, Rustagi Sarvesh, Nazli Khatib Mahalaqua, Kumar Mishra Sunil, Sah Sanjit, Abu Serhan Hashem, Bushi Ganesh, Padhi Bijaya K
University Center for Research and Development, Chandigarh University, Mohali, Punjab, India.
Medical Laboratories Techniques Department, AL-Mustaqbal University, 51001 Hillah, Babil, Iraq.
J Clin Transl Endocrinol. 2024 Nov 22;39:100374. doi: 10.1016/j.jcte.2024.100374. eCollection 2025 Mar.
Diabetes mellitus presents significant public health challenges worldwide. While its prevalence and management in the general population have been extensively studied, comprehensive research on diabetes among incarcerated individuals is lacking. This study aims to conduct a systematic review and -analysis to determine the prevalence of diabetes within the prison population.
The systematic review included studies reporting on the prevalence of diabetes in prison populations. Searches were conducted in PubMed, Web of Science, and EMBASE from 2000 to November 4, 2023, with an update on December 15, 2023. Nested Knowledge web software was utilized for screening and data extraction. Quality assessment was conducted using the JBI tool. A -analysis was performed using a random-effects model in R software version 4.3.
Thirty-three studies were included, encompassing 807,617 participants, with 67,291 reported as patients with diabetes. The pooled prevalence of diabetes in prison populations was found to be 7.1% (95% CI: 4.9% to 10.1%), exhibiting high heterogeneity (I = 100%). Subgroup analysis revealed significant geographical variability: the United States had a prevalence of 9% (95% CI: 4 %to 17 %), Italy 5% (95% CI: 0% to 40 %), Iran 10% (95% CI: 7 % to 15 %), and Egypt 21% (95% CI: 14% to 28 %). Notable variations in prevalence were also observed in countries like France, Australia, Taiwan, India, the UK, Spain, Brazil, and Sub-Saharan Africa. An LFK index of -3.3 indicated the presence of publication bias.
The study reveals that diabetes mellitus is a significant health concern in prisons, with a prevalence of 7.1%, comparable to that in the general population. The marked variability across studies indicates the challenges of diabetes management in correctional settings. These findings highlight the need for tailored healthcare strategies, considering prisons' unique challenges and risk factors.
糖尿病在全球范围内带来了重大的公共卫生挑战。虽然其在普通人群中的患病率和管理情况已得到广泛研究，但针对被监禁人群中的糖尿病却缺乏全面研究。本研究旨在进行系统评价和分析，以确定监狱人群中糖尿病的患病率。
该系统评价纳入了报告监狱人群中糖尿病患病率的研究。于2000年至2023年11月4日在PubMed、科学网和EMBASE中进行检索，并于2023年12月15日进行了更新。使用Nested Knowledge网络软件进行筛选和数据提取。采用JBI工具进行质量评估。在R软件版本4.3中使用随机效应模型进行分析。
纳入了33项研究，涵盖807,617名参与者，其中67,291名报告为糖尿病患者。监狱人群中糖尿病的合并患病率为7.1%（95%置信区间：4.9%至10.1%），显示出高度异质性（I² = 100%）。亚组分析显示出显著的地域差异：美国患病率为9%（95%置信区间：4%至17%），意大利为5%（95%置信区间：0%至40%），伊朗为10%（95%置信区间：7%至15%），埃及为21%（95%置信区间：14%至28%）。在法国、澳大利亚、台湾、印度、英国、西班牙、巴西和撒哈拉以南非洲等国家也观察到患病率的显著差异。-3.3的LFK指数表明存在发表偏倚。
该研究表明，糖尿病是监狱中的一个重大健康问题，患病率为7.1%，与普通人群相当。各研究之间的显著差异表明了惩教机构中糖尿病管理的挑战。这些发现凸显了制定针对性医疗保健策略的必要性，需考虑监狱独特的挑战和风险因素。
